Lloyd, K. A., Parsons, B. N., Burkitt, M. D., Moore, A. R., Papoutsopoulou, S., Boyce, M., Duckworth, C. A., Exarchou, K., Howes, N., Rainbow, L., Fang, Y.
, Oxvig, C., Dodd, S., Varro, A., Hall, N. & Pritchard, D. M. (2020).
Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
Cellular and Molecular Gastroenterology and Hepatology,
10(1), 113-132.
https://doi.org/10.1016/j.jcmgh.2020.01.010
